UNIVERSITY OF ARIZONA

- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.arizona.edu
Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-09-09
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- University of Arizona
- Registration Number
- NCT00091325
- Locations
- 🇺🇸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States
Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
- Conditions
- LeukemiaMyelodysplastic Syndromes
- First Posted Date
- 2004-08-03
- Last Posted Date
- 2013-01-31
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 26
- Registration Number
- NCT00003415
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
- Conditions
- Breast CancerDrug/Agent Toxicity by Tissue/Organ
- First Posted Date
- 2004-08-02
- Last Posted Date
- 2013-01-31
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 30
- Registration Number
- NCT00003068
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer
- Conditions
- Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 27
- Registration Number
- NCT00003082
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer
- Conditions
- Prostate CancerRadiation Toxicity
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 25
- Registration Number
- NCT00003307
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
Selenium for Prevention of Adenomatous Colorectal Polyps
- Conditions
- Precancerous ConditionColorectal CancerAdenomatous Colorectal Polyps
- Interventions
- First Posted Date
- 2004-03-09
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 1621
- Registration Number
- NCT00078897
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Phoenix, Phoenix, Arizona, United States
🇺🇸Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
- Conditions
- Precancerous/Nonmalignant ConditionNon-melanomatous Skin Cancer
- First Posted Date
- 2004-02-16
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- University of Arizona
- Registration Number
- NCT00021294
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
Multidisciplinary Study of Right Ventricular Dysplasia
- Conditions
- Heart DiseasesArrhythmogenic Right Ventricular Dysplasia
- First Posted Date
- 2001-09-18
- Last Posted Date
- 2013-01-17
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 320
- Registration Number
- NCT00024505
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
Bone Estrogen Strength Training
- Conditions
- Osteoporosis
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2013-05-20
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 300
- Registration Number
- NCT00000399
- Locations
- 🇺🇸
Ina Gittings Bldg. Body Composition Laboratory, Tucson, Arizona, United States